Skip to Content

TEVA 7031 (Mycophenolic Acid Delayed-Release 180 mg)

Pill with imprint TEVA 7031 is Green, Round and has been identified as Mycophenolic Acid Delayed-Release 180 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Mycophenolic acid is used in the treatment of rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7031

Mycophenolic acid delayed-release 180 mg TEVA 7031

Mycophenolic Acid Delayed-Release

Imprint
TEVA 7031
Strength
180 mg
Color
Green
Shape
Round
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7031

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.